Agresta Samuel 4
4 · Foghorn Therapeutics Inc. · Filed Jan 28, 2022
Insider Transaction Report
Form 4
Agresta Samuel
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-26+125,000→ 125,000 totalExercise: $14.87Exp: 2032-01-25→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The option vested as to 25% of the underlying shares of common stock on January 26, 2023, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested.